CYTOF
Altamira Therapeutics Ltd.
$0.06
+0.00 (+0.00%)
At close · Jul 7
Market Cap
$365,790
Shares
5,715,472
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-8.2M
-23.6%
FY2020
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|
| CHF | 2.86M | 3.33M | 6.69M | 19.21M |
| CHF | 2.59M | 3.93M | 4.26M | 5.15M |
| CHF | -8.2M | -6.63M | -11.5M | — |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.